Oncology Live®
Vol. 24/No. 20
Volume: 24
Issue: 20
Vol. 24/No. 18
Volume: 24
Vol. 24/No. 19
Volume: 24
Issue: 19
Vol. 24/No. 17
Volume: 24
Issue: 17
Vol. 24/No. 16
Volume: 24
Issue: 16
Vol. 24/No. 15
Volume: 24
Issue: 15
Vol. 24/No. 14
Volume: 24
Issue: 14
Vol. 24/No. 12
Volume: 24
Vol. 24/No. 13
Volume: 24
Issue: 13
Vol.24/No.11
Volume: 24
Issue: 11
Vol. 24/ No. 10
Volume: 24
Issue: 10
Vol. 24/No. 9
Volume: 24
Issue: 9
Vol. 24/No. 8
Volume: 24
Vol.24/No.7
Vol. 24/No. 5
Volume: 24
Vol. 24/No. 6
Volume: 24
Issue: 6
Vol. 24/No. 4
Volume: 24
Vol. 24/No. 3
Volume: 24
Vol. 24/No. 2
Volume: 24
Issue: 2
Vol. 24/No. 1
Volume: 24
Issue: 1
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
3
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
4
Dr Riedell on the Long-Term Efficacy of Tisa-Cel in R/R Follicular Lymphoma
5